AhmedMofrehAlkalibyMDMSc., PhD., MRCS Edin and Glasg, FICO

Ophthalmology • Traverse City, MI

Retinal Disease

Vitreoretinal Consultant/Surgeon

Join to view full profile

Dr. Alkaliby is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Alkaliby's full profile

Already have an account?

Office
860 E Front St
Traverse City, MI 49686
Phone+1 231-938-0710

Summary

Cataract and Vitreoretinal Surgery

Education & Training

University of California (Irvine)Fellowship, Surgical Retina and Vitreous, 2019 - 2021
Instituto de Microcirugía OcularMD, Retina, 2019 - 2019
University Retina and Macula associatesVisiting Fellow, Retina And Vitreous, 2018 - 2018
Tanta University Faculty of MedicineClass of 2011

Certifications & Licensure

IL State Medical License 2022 - 2026
MI State Medical License 2022 - 2025
OH State Medical License 2021 - 2025
CA State Medical License 2020 - 2022

Awards, Honors, & Recognition

Diamond Jubil Award APAO, 2021

Clinical Trials

Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP) Start of enrollment: 2021 Feb 01
Recruiting
Phase 2
Stem Cells Therapy in Degenerative Diseases of the Retina Start of enrollment: 2018 Dec 13
Enrolling by invitation
Phase 1
Stem Cell Ophthalmology Treatment Study Start of enrollment: 2012 Aug 01
Enrolling by invitation
Not Applicable
Stem Cell Ophthalmology Treatment Study II Start of enrollment: 2016 Jan 01
Recruiting
Not Applicable
Stem Cell Models of Best Disease and Other Retinal Degenerative Diseases. Start of enrollment: 2014 Feb 01
Completed
Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy Start of enrollment: 2012 Jul 01
Active, not recruiting
Phase 1
Stem Cell Therapy for Outer Retinal Degenerations Start of enrollment: 2015 Aug 01
Completed
Phase 1, Phase 2
Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration Diseases Start of enrollment: 2015 May 01
Unknown status
Phase 1, Phase 2
Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells Start of enrollment: 2019 Apr 01
Completed
Phase 3
Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa Start of enrollment: 2021 Jun 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

CMV retinitis in patients on mycophenolate immunosuppression: a report of two cases.
Prem N Patel, Ahmed M Alkaliby, Mitul C Mehta, Angeline L Wang
Allergy, Asthma, and Clinical Immunology. 2023-08-19